Detalhe da pesquisa
1.
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
N Engl J Med
; 390(2): 132-142, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38197816
2.
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
N Engl J Med
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38739079
3.
In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo.
Ann Intern Med
; 177(3): JC30, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38437698
4.
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
J Card Fail
; 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38493832
5.
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy.
J Card Fail
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38065306
6.
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis.
J Card Fail
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38065307
7.
Imaging cardiac hypertrophy in hypertrophic cardiomyopathy and its differential diagnosis.
Curr Opin Cardiol
; 38(5): 397-404, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37421401
8.
Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics.
Curr Cardiol Rep
; 25(6): 583-595, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37103749
9.
Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Curr Heart Fail Rep
; 20(6): 504-518, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37875744
10.
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy.
JAMA
; 330(15): 1448-1458, 2023 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37768671
11.
Clinical management of amyloid cardiomyopathy.
Heart Fail Rev
; 27(5): 1549-1557, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34471997
12.
Liver-directed drugs for transthyretin-mediated amyloidosis.
J Peripher Nerv Syst
; 27(4): 228-237, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36345805
13.
Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
Pacing Clin Electrophysiol
; 45(1): 124-131, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34806769
14.
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.
Cardiovasc Ultrasound
; 20(1): 23, 2022 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36117179
15.
Approach to echocardiography in ARDS patients in the prone position: A systematic review.
Echocardiography
; 39(2): 330-338, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35043474
16.
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 396(10253): 759-769, 2020 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32871100
17.
Assessment of right ventricular function following left ventricular assist device (LVAD) implantation-The role of speckle-tracking echocardiography: A meta-analysis.
Echocardiography
; 37(12): 2048-2060, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33084128
18.
A rare case of bowel intussusception due to adenocarcinomatous polyp in a 14 year-old child: case report.
BMC Surg
; 20(1): 198, 2020 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32917174
19.
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
Eur J Nucl Med Mol Imaging
; 51(3): 691-694, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38110712
20.
Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
Catheter Cardiovasc Interv
; 94(3): E104-E110, 2019 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30690850